Recent Finacing
Recent Raise
Auctus Biologics develops RPtag, a hyper-stable antibody-mimetic scaffold designed for oral delivery to target immunosenescence and gastrointestinal indications.
Focus Areas
Total Raised
Funding round
See the team members at Auctus Biologics.
